The effects of somatostatin analogs on biochemical parameters in acromegaly.
Liuzzi
A
A
Department of General Medicine, Ospedale S. Giuseppe, IRCCS Istituto Auxologico Italiano, Verbania, Italy. liuzzi@auxologico.it
Marzullo
P
P
D000172:Acromegaly / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D000236:Adenoma / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D004351:Drug Resistance; D019382:Human Growth Hormone / Q000187:drug effects*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000187:drug effects*; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D017481:Receptors, Somatostatin / Q000145:classification / Q000187:drug effects; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D017481:Receptors, Somatostatin; D019382:Human Growth Hormone; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I